Longhorn Vaccines and Diagnostics to Present New Data on DRG5--BD11 Showing Broad Activity Against Multiple Bacterial Classes at ESCMID 2026

Longhorn Vaccines and Diagnostics (LHNVD), an IND enabling-stage biopharmaceutical company, today announced it will present new preclinical data demonstrating that DRG5--BD11, a novel human bispecific ...
Yahoo Finance

IGM Bio (IGMS) Stock Rallies 142% in 3 Months: Here's Why

IGM Biosciences IGMS, a clinical-stage company, is developing a pipeline of Immunoglobin M (IgM) antibody-based candidates to treat patients with cancer and autoimmune and inflammatory diseases. The ...
Seeking Alpha

IGM: Mag 7's P/E Has Come Down Ahead Of Q1 Earnings, But Technical Damage Done

IGM has seen a significant rebound but remains fairly valued with a mixed technical outlook, leading me to maintain a hold rating. The ETF's heavy exposure to the Mag 7 stocks and high volatility are ...
Onlymyhealth

IgM and IgG Antibody Testing in Diagnosing Dengue, All You Need To Know

The country is seeing a massive dengue outbreak as thousands of cases are being reported monthly. This is a mosquito-borne illness that begins in the monsoon(mosquito ...
Nasdaq

IGM Biosciences Announces Strategic Pivot to Focus Exclusively on Autoimmunity

MOUNTAIN VIEW, Calif., Sept. 30, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today ...
FierceBiotech

IGM, with cash dipping below $390M, cuts head count 22%, stops blood cancer work to stretch money

How much money does a biotech need to feel comfortable in today’s market? IGM Biosciences added to evidence that the number is big after the market closed Tuesday, when it revealed a 22% reduction in ...